Regulation of adipokines by polyunsaturated fatty acids in a rat model of non-alcoholic steatohepatitis

Archives of Iranian Medicine

Volumn 17, Issue 8, 2014, Pages 563-568

  Ding, Wen Jin ^a   Wang, Ye ^a   Fan, Jian Gao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adipokines; Non alcoholic steatohepatitis; Polyunsaturated fatty acid

Indexed keywords

ADIPOCYTOKINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LEPTIN; MESSENGER RNA; POLYUNSATURATED FATTY ACID; RESISTIN; ADIPOKINES; ADIPONECTIN; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; RNA, MESSENGER;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIVER LEVEL; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; WESTERN BLOTTING; ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DRUG EFFECTS; GENETICS; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; RATS; RATS, SPRAGUE-DAWLEY;

ADIPOKINES; ADIPONECTIN; ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; LEPTIN; LIVER; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; RATS; RATS, SPRAGUE-DAWLEY; RESISTIN; RNA, MESSENGER;

EID: 84905243140     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Yilmaz Y, Colak Y, Kurt R, Senates E, Eren F. Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back. Tumori. 2013; 99: 10-16.
2. Masuoka HC, Chalasani N. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann N Y Acad Sci. 2013; 1281: 106-122.
3. Tilg H. Adipokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis. Curr Pharm Des. 2010; 16: 1893-1895.
4. Marsman HA, Heger M, Kloek JJ, Nienhuis SL, Van Werven, JR, Nederveen AJ, et al. Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectros-copy in a rat model. J Gastroenterol Hepatol. 2011; 26: 356-363.
5. Xu ZJ, Fan JG, Ding XD, Qiao L, Wang GL. Characterization of high-fat diet-induced non-alcoholic steatohepatitis with fibrosis in rats. Dig Dis Sci. 2010; 55: 931-940.
6. Fedor D, Kelly DS. Prevention of insulin resistance by n-3 ployun-saurated fatty acids. Curr Opin Clin Nutr Metab Care. 2009; 12: 138-146.
7. Parker HM, Johnson NA, Burdon CA, Cohn JS, O'Connor HT, George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012; 56: 944-951.
8. Buckley JD, Howe PR. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acid. Obes Rev. 2009; 10: 648-659.
9. Safar Zadeh E, Lungu AO, Cochran EK, Brown RJ, Ghany MG, Heller T, et al. The liver diseases of lipodystrophy: The long-term effect of leptin treatment. J Hepatol. 2013; 59: 131-137.
10. Machado MV, Coutinho J, Carepa F, Costa A, Proenca H, Cortez-Pinto H. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2012; 24: 1166-1172.
11. Li YL, Yang M, Meng XD, He XH, Wang BY. The relationship of leptin and adiponectin with insulin resistance in nonalcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi. 2010; 18: 459-462.
12. Yazici D, Yavuz D, Ogiinc AV, Sirikci O, Toprak A, Deyneli O, et al. Serum Adipokine Levels in Type 1 Diabetic Patients: Association with Carotid Intima Media Thickness. Metab Syndr Relat Disord. 2012; 10: 26-31.
13. Zhou YJ, Li YY, Nie YQ, Yang H, Zhan Q, Huang J, et al. Influence Polyunsaturated Fatty Acids and Non-alcoholic Steatohepatitis of polygenetic polymophisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people. J Gastroenterol Hepatol. 2010; 25: 772-777.
14. Gan RT, Yang SS. The 223A>G polymorphism of the leptin receptor gene is associated with macroangiopathy in type 2 diabetes mellitus. Mol Biol Rep. 2012; 39: 4759-4764.
15. Jiang LL, Li L, Hong XF, Li YM, Zhang BL. Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels. Eur J Gastroenterol Hepatol. 2009; 21: 662-666.
16. Gatselis NK, Ntaios G, Makaritsis K, Dalekos GN. Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. Clin Exp Med. 2014; 14: 121-131. doi: 10.1007/s10238-012-0227-0. Epub 2013 Jan 5
17. Balmer ML, Joneli J, Schoepfer A, Stickel F, Thormann W, Dufour JF. Significance of serum adiponection levels in patients with chronic liver disease. Clin Sci (Lond). 2010; 119: 431-436.
18. Arvaniti VA, Thomopoulos KC, Tsamandas A, Makri M, Psyrogiannis A, Vafiadis G, et al. Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis.Acta GastroenterolBelg. 2008; 71: 355-360.
19. Ding WJ, Duan XY, Fan JG. The efficacy of to-3 polyunsaturated fatty acid on rats with non-alcoholic steatohepatitis. Hepatology International (abstract book). 2011; 5(1): 196.